Effects of immunosuppressive treatment on protein expression in rat kidney

Karolina Kędzierska1, Katarzyna Sporniak-Tutak2, Krzysztof Sindrewicz2

  • 1Department of Nephrology, Transplantology, and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.

Insights

Immunosuppressants alter kidney protein expression, particularly affecting drug metabolism and cellular structures. Tacrolimus-based regimens showed more significant changes than cyclosporine-based ones, impacting renal function markers.

Area of Science:

  • Nephrology
  • Pharmacology
  • Proteomics

Background:

  • Immunosuppressive drugs can exhibit nephrotoxicity through mechanisms potentially involving toxic metabolites affecting renal tubular epithelial cells.
  • Understanding the impact of different immunosuppressive strategies on kidney protein expression is crucial for managing drug-induced toxicity.

Purpose of the Study:

  • To investigate the effects of two distinct immunosuppressive strategies on the proteome of Wistar rat kidneys.
  • To compare the protein expression profiles induced by cyclosporine, mycophenolate mofetil, and glucocorticoids (CMG) versus tacrolimus, mycophenolate mofetil, and glucocorticoids (TMG).

Main Methods:

  • Kidney tissue homogenization and lysis.
  • Protein concentration determination using a protein assay kit.
  • Two-dimensional electrophoresis for protein separation, followed by Coomassie Brilliant Blue staining and image analysis.
  • Mass spectrometry for identification of differentially expressed proteins.

Main Results:

  • Both immunosuppressive regimens induced significant changes in protein expression, notably affecting proteins involved in drug, glucose, amino acid, and lipid metabolism.
  • The TMG group showed increased expression of renal drug metabolism proteins and decreased expression of cytoplasmic actin and major urinary protein compared to controls.
  • Compared to the CMG group, the TMG group exhibited higher expression of drug metabolism proteins, decreased respiratory chain enzymes (thioredoxin-2), and reduced markers of distal renal tubular damage (heart fatty acid-binding protein).

Conclusions:

  • Immunosuppressive drug regimens significantly alter kidney proteomes, with notable impacts on metabolic pathways and structural proteins.
  • The TMG regimen induced more pronounced changes in renal drug metabolism proteins and markers of tubular damage compared to the CMG regimen.
  • Further research is needed to elucidate the clinical consequences of these observed protein expression changes on renal function and toxicity.